This Is AI Understanding Women’s Health
In this video, Barbara Engelhardt and Deepak Srivastava explain how AI can be used to empower women to understand how their periods reflect their health.
Licensing
Gladstone maintains an active and diverse intellectual property (IP) portfolio around technologies, novel approaches to treating disease, and specific therapies.
Several options for licensing Gladstone IP are available to both new start-ups, established companies, and research institutions.
CONTACT
Contact the Corporate Liaison and Ventures Team for more information on licensing opportunities
IP PORTFOLIO
Explore Our IP Portfolio
Latest News
Read
How AI Is Filling the Gaps in Women’s Health Research
A Gladstone-led study is collecting data from thousands of women wearing Oura Rings to make sense of what’s normal—and what could signal problems—when it comes to the menstrual cycle.
Read
Christina Theodoris to Receive ASCI’s 2026 Seldin-Smith Award for Pioneering Research
The prestigious honor is presented by the American Society for Clinical Investigation to a physician-scientist making transformative contributions to biomedical research.
Read
Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
Read
In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now